The association between drug injection duration and hepatitis C prevalence among people who inject drugs in Iran

被引:0
作者
Haji-Maghsoudi, Saiedeh [1 ]
Tavakoli, Fatemeh [2 ,3 ]
Mehmandoost, Soheil [2 ,3 ]
Nasiri, Naser [2 ,3 ,4 ]
Haghdoost, Ali Akbar [6 ]
Sharifi, Hamid [2 ,3 ,5 ]
机构
[1] Kerman Univ Med Sci, Inst Futures Studies Hlth, Modeling Hlth Res Ctr, Kerman, Iran
[2] Kerman Univ Med Sci, HIV STI Surveillance Res Ctr, Kerman, Iran
[3] Kerman Univ Med Sci, Inst Futures Studies Hlth, WHO Collaborating Ctr HIV Surveillance, Kerman, Iran
[4] Jiroft Univ Med Sci, Sch Publ Hlth, Dept Epidemiol & Biostat, Jiroft, Iran
[5] Univ Calif San Francisco, Inst Global Hlth Sci, San Francisco, CA 94143 USA
[6] Kerman Univ Med Sci, Inst Futures Studies Hlth, Social Determinants Hlth Res Ctr, Kerman, Iran
关键词
Hepatitis C; Substance abuse; Intravenous; Additive models; Iran; VIRUS; HIV; HCV; AGE; PRISON; RISK;
D O I
10.1038/s41598-025-94867-5
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
People who inject drugs (PWID) are at higher risk of hepatitis C virus (HCV) due to their behaviors such as shared injection. Employing appropriate modeling approaches is crucial for accurately evaluating the impact of other variables on outcomes, in this case, HCV seropositivity. This study aimed to assess the non-linear effect of injection duration on HCV seropositivity. From July 2019 to March 2020, 2,684 PWID in Iran were recruited. The binary outcome variable was HCV serostatus (positive vs. negative), determined by detecting HCV antibodies. The non-linear effect of injection duration on HCV seropositivity was assessed using a multilevel Generalized Additive Model in R software, adjusting the effects of other variables in the analysis. We found a non-linear effect of injection duration on HCV seropositivity status (p-value < 0.001). The probability of HCV seropositivity increased with injection duration, though this relationship was non-linear. Initially, the probability rises faster; however, this effect diminishes as the injection duration extends. An initial sharp increase in HCV risk was seen during the first 20 years of injection. HCV seropositivity was notably associated with ever HIV seropositivity (OR [Odds Ratio] = 10.54, 95% CI [Confidence Interval]: 5.39, 20.61, p-value < 0.001), ever having injected methamphetamine (OR = 1.72, 95% CI: 1.33, 2.22, p-value < 0.001), being currently married (OR = 0.67, 95% CI: 0.48, 0.93, p-value = 0.018), ever shared needle/syringe with others (OR = 2.63, 95% CI: 1.32, 5.22, p-value = 0.006), and ever being incarcerated (OR = 1.97, 95% CI: 1.50, 2.58, p-value < 0.001). Our study contributes to the field by demonstrating that a non-linear approach can reveal patterns of risk that linear models might fail to capture. These findings indicate that the relationship between injection duration and HCV seropositivity can be more complex than previously understood, underscoring the importance of employing more advanced modeling techniques in future research.
引用
收藏
页数:10
相关论文
共 48 条
[1]   Prevalence of injecting drug use and HIV, hepatitis B, and hepatitis C in people who inject drugs in the Eastern Mediterranean region: a systematic review and meta-analysis [J].
Aghaei, Ardavan Mohammad ;
Gholami, Jaleh ;
Sangchooli, Arshiya ;
Rostam-Abadi, Yasna ;
Olamazadeh, Sogol ;
Ardeshir, Maryam ;
Baheshmat, Shahab ;
Shadloo, Behrang ;
Taj, Mahshid ;
Saeed, Khalid ;
Rahimi-Movaghar, Afarin .
LANCET GLOBAL HEALTH, 2023, 11 (08) :E1225-E1237
[2]   The effects of needle-sharing and opioid substitution therapy on incidence of hepatitis C virus infection and reinfection in people who inject drugs [J].
Aitken, C. K. ;
Agius, P. A. ;
Higgs, P. G. ;
Stoove, M. A. ;
Bowden, D. S. ;
Dietze, P. M. .
EPIDEMIOLOGY AND INFECTION, 2017, 145 (04) :796-801
[3]   Incidence of HIV and hepatitis C virus among people who inject drugs, and associations with age and sex or gender: a global systematic review and meta-analysis [J].
Artenie, Adelina ;
Stone, Jack ;
Fraser, Hannah ;
Stewart, Daniel ;
Arum, Chiedozie ;
Lim, Aaron G. ;
Trickey, Adam ;
Ward, Zoe ;
Abramovitz, Daniela ;
Alary, Michel ;
Astemborski, Jacquie ;
Bruneau, Julie ;
Clipman, Steven J. ;
Coffin, Carla S. ;
Croxford, Sara ;
Debeck, Kora ;
Emanuel, Eva ;
Hayashi, Kanna ;
Hermez, Joumana G. ;
Low-Beer, Daniel ;
Luhmann, Niklas ;
Macphail, Gisela ;
Maher, Lisa ;
Palmateer, Norah E. ;
Patel, Eshan U. ;
Sacks-Davis, Rachel ;
Van Den Boom, Wijnand ;
van Santen, Daniel K. ;
Walker, Josephine G. ;
Hickman, Matthew ;
Vicerman, Peter .
LANCET GASTROENTEROLOGY & HEPATOLOGY, 2023, 8 (06) :533-552
[4]   Diversity of incarceration patterns among people who inject drugs and the association with incident hepatitis C virus infection [J].
Artenie, Andreea Adelina ;
Hickman, Matthew ;
Vickerman, Peter ;
Stone, Jack ;
Grebely, Jason ;
Bruneau, Julie .
INTERNATIONAL JOURNAL OF DRUG POLICY, 2021, 96
[5]  
Arum C, 2021, LANCET PUBLIC HEALTH, V6, pE309, DOI [10.1016/S2468-2667(21)00013-X, 10.1016/S2468-2667(21)00013]
[6]   Unweighted regression models perform better than weighted regression techniques for respondent-driven sampling data: results from a simulation study [J].
Avery, Lisa ;
Rotondi, Nooshin ;
McKnight, Constance ;
Firestone, Michelle ;
Smylie, Janet ;
Rotondi, Michael .
BMC MEDICAL RESEARCH METHODOLOGY, 2019, 19 (01)
[7]   Effects of duration of injection drug use and age at first injection on HCV among IDU in Kabul, Afghanistan† [J].
Bautista, Christian T. ;
Todd, Catherine S. ;
Abed, Abdullah M. S. ;
Botros, Boulos A. ;
Strathdee, Steffanie A. ;
Earhart, Kenneth C. ;
Safi, Naqibullah ;
Scott, Paul T. .
JOURNAL OF PUBLIC HEALTH, 2010, 32 (03) :336-341
[8]   Ties, sites and irregularities: pitfalls and benefits in using respondent-driven sampling for surveying a homeless population [J].
Bernard, Josef ;
Dankova, Hana ;
Vasat, Petr .
INTERNATIONAL JOURNAL OF SOCIAL RESEARCH METHODOLOGY, 2018, 21 (05) :603-618
[9]   Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study [J].
Blach, Sarah ;
Terrault, Norah A. ;
Tacke, Frank ;
Gamkrelidze, Ivane ;
Craxi, Antonio ;
Tanaka, Junko ;
Waked, Imam ;
Dore, Gregory J. ;
Abbas, Zaigham ;
Abdallah, Ayat R. ;
Abdulla, Maheeba ;
Aghemo, Alessio ;
Aho, Inka ;
Akarca, Ulus S. ;
Alalwan, Abduljaleel M. ;
Blome, Marianne Alanko ;
Al-Busafi, Said A. ;
Aleman, Soo ;
Alghamdi, Abdullah S. ;
Al-Hamoudi, Waleed K. ;
Aljumah, Abdulrahman A. ;
Al-Naamani, Khalid ;
Al Serkal, Yousif M. ;
Altraif, Ibrahim H. ;
Anand, Anil C. ;
Anderson, Motswedi ;
Andersson, Monique, I ;
Athanasakis, Kostas ;
Baatarkhuu, Oidov ;
Bakieva, Shokhista R. ;
Ben-Ari, Ziv ;
Bessone, Fernando ;
Biondi, Mia J. ;
Bizri, Abdul Rahman N. ;
Mello, Carlos E. Brandaoo ;
Brigida, Krestina ;
Brown, Kimberly A. ;
Brown, Robert S., Jr. ;
Bruggmann, Philip ;
Brunetto, Maurizia R. ;
Busschots, Dana ;
Buti, Maria ;
Butsashvili, Maia ;
Cabezas, Joaquin ;
Chae, Chungman ;
Ivanova, Viktorija Chaloska ;
Chan, Henry Lik Yuen ;
Cheinquer, Hugo ;
Cheng, Kent Jason ;
Cheon, Myeong Eun .
LANCET GASTROENTEROLOGY & HEPATOLOGY, 2022, 7 (05) :396-415
[10]   Estimating the contribution of stimulant injection to HIV and HCV epidemics among people who inject drugs and implications for harm reduction: A modeling analysis [J].
Cepeda, Javier A. ;
Vickerman, Peter ;
Bruneau, Julie ;
Zang, Geng ;
Borquez, Annick ;
Farrell, Michael ;
Degenhardt, Louisa ;
Martin, Natasha K. .
DRUG AND ALCOHOL DEPENDENCE, 2020, 213